Pharmaceuticals company Torrent Pharmaceuticals announced Q1FY26 results Revenue at Rs 3,178 crore; grew by 11% YoY India revenues at Rs 1,811 crore were up by 11% led by outperformance in focus therapies. Brazil revenues at Rs 218 crore, were up by 11%. Germany revenues at Rs 308 crore, were up by 9% US business revenues at Rs 308 crore, were up by 19%. Op. EBITDA at Rs 1,032 crore, up by 14% YoY Op. EBITDA margin at 32.5%; Gross Margin: 76% Includes acquisition related one-off expenses of Rs 15 crore. Op. EBITDA adjusted for these one-offs is 1,047 crore, with a margin of 32.9% Net Profit after tax at Rs 548 crore, up by 20% YoY. R&D; spend stood at Rs 157 crore compared to Rs 135 crore up 16% Result PDF